Utility of clinical, laboratory, and lymph node MYD88 L265P mutation in risk assessment of diffuse large B-cell lymphoma patients
Abstract Background Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma and is characterized by heterogeneity in biology and clinical behavior. Mutations in the myeloid differentiation primary response 88 (MYD88) are found in different lymphoproliferative disorders and are as...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SpringerOpen
2024-10-01
|
| Series: | Journal of the Egyptian National Cancer Institute |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s43046-024-00237-z |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|